Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population

被引:24
作者
Csaszar, Albert
Kekes, Ede
Abel, Tanja
Papp, Renata
Kiss, Istvan
Balogh, Sandor
机构
[1] Natl Med Ctr, Dept Med, Budapest, Hungary
[2] St Imre Hosp, Int Med Serv, Budapest, Hungary
[3] St Imre Hosp, Natl Inst Primary Hlth Care, Budapest, Hungary
[4] St Imre Hosp, Dept Med 4, Budapest, Hungary
关键词
Hungarian population; IDF; metabolic syndrome; prevalence;
D O I
10.1080/08037050600772284
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aims: In recent years, metabolic syndrome (MS) became a distinct pathological entity. MS is positively associated with cardiovascular mortality. The prevalence of MS is high and a continuing increase is expected. For this reason, all attempts to prevent or manage MS by interventions are extremely important. The new set of definition by International Diabetes Federation (IDF) standardizes criteria for the diagnosis of MS and facilitates its recognition. In a large sample (n =13 383) of outpatients visiting their general practitioners, we determined the prevalence of risk factors of MS according to the earlier Adult Treatment Panel (ATP) III and the new IDF criteria. Methods and results. The age-standardized prevalence of MS was 14.9% in males and 8.6% in females (11.5% for all). The most prevalent factors were obesity (ATP III: 38.8% and IDF: 60%) and hypertriglyceridemia (34.1%). Hypertension dominated in men (28.7%), whereas in women obesity was the most prevalent factor (ATP III: 47.4% and IDF: 64%). Conclusion. The prevalence of MS depends on applied definition. The new IDF criteria offer the possibility of focusing on the importance of different components. The real comparison of prevalence among special populations has to be based on age- standardized data and the use of the same components. In our study, the dominance of obesity, hypertension and hypertriglyceridemia appears to be the major detrimental factors. The 11.5% general prevalence of MS in Hungarians, which means a 25-30% value in the middle- aged population, needs an urgent preventive approach with lifestyle changes.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 21 条
[1]  
AIZAWA Y, 2005, INT J CARDIOL
[2]   Prevalence of metabolic syndrome in the Spanish working population:: MESYAS registry [J].
Alegría, E ;
Cordero, A ;
Laclaustra, M ;
Grima, A ;
León, M ;
Casasnovas, JA ;
Luengo, E ;
del Río, A ;
Ferreira, I .
REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (07) :797-806
[3]   Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METSGREECE Multicentre Study [J].
Athyros, VG ;
Mikhailidis, DP ;
Papageorgiou, AA ;
Didangelos, TP ;
Ganotakis, ES ;
Symeonidis, AN ;
Daskalopoulou, SS ;
Kakafika, AI ;
Elisaf, M .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (11) :1691-1701
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   Higher prevalence of type 2 diabetes, metabolic syndrome and cardiovascular diseases in gypsies than in non-gypsies in Slovakia [J].
de Courten, BV ;
de Courten, M ;
Hanson, RL ;
Zahorakova, A ;
Egyenes, HP ;
Tataranni, PA ;
Bennett, PH ;
Vozar, J .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 62 (02) :95-103
[6]   Metabolic syndrome and 10-year cardiovascular disease risk in the hoorn study [J].
Dekker, JM ;
Girman, C ;
Rhodes, T ;
Nijpels, G ;
Stehouwer, CDA ;
Bouter, LM ;
Heine, RJ .
CIRCULATION, 2005, 112 (05) :666-673
[7]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[8]   A comparison of the prevalence of the metabolic syndrome using two proposed definitions [J].
Ford, ES ;
Giles, WH .
DIABETES CARE, 2003, 26 (03) :575-581
[9]   Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence [J].
Ford, ES .
DIABETES CARE, 2005, 28 (07) :1769-1778
[10]   Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].
Grundy, SM ;
Cleeman, JI ;
Daniels, SR ;
Donato, KA ;
Eckel, RH ;
Franklin, BA ;
Gordon, DJ ;
Krauss, RM ;
Savage, PJ ;
Smith, SC ;
Spertus, JA ;
Costa, F .
CURRENT OPINION IN CARDIOLOGY, 2006, 21 (01) :1-6